Literature DB >> 3021937

The prevalence of screening in industry: report from the National Institute for Occupational Safety and Health National Occupational Hazard Survey.

J M Ratcliffe, W E Halperin, T M Frazier, D S Sundin, L Delaney, R W Hornung.   

Abstract

Data from 4,500 workplaces surveyed by the National Institute for Occupational Safety and Health (NIOSH) in the National Occupational Hazard Survey (1972 to 1974) and National Occupational Exposure Survey (1981 to 1983) show an increase in both preplacement and periodic medical screening in US industries during the past decade. The distribution of screening is primarily related to plant size, but also varies considerably by industry type; further, plants with industrial hygiene and safety programs and/or unions are more likely to provide screening examinations than those without, irrespective of plant size. As for workers potentially exposed to selected chemical hazards, the first survey provides no consistent evidence that such workers were more likely to receive exposure-specific tests than other workers. The significance of these findings is discussed in the context of the proposed framework for medical screening practices developed by NIOSH researchers.

Entities:  

Mesh:

Year:  1986        PMID: 3021937     DOI: 10.1097/00043764-198610000-00003

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  3 in total

1.  Biological monitoring and medical screening at the workplace in the EC countries.

Authors:  K Rasmussen; P Lunde-Jensen; O Svane
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

2.  Environmental and biological monitoring for lead exposure in California workplaces.

Authors:  L Rudolph; D S Sharp; S Samuels; C Perkins; J Rosenberg
Journal:  Am J Public Health       Date:  1990-08       Impact factor: 9.308

3.  Company characteristics and workplace medical testing.

Authors:  L I Boden; H Cabral
Journal:  Am J Public Health       Date:  1995-08       Impact factor: 9.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.